首页> Cell death & disease> Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.

Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.

导出 OA

翻译打印收藏纠错

第一作者： Tingyu,Wu

第一单位： Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Shanghai Colorectal Cancer Research Center, Shanghai, China.

作者： Tingyu,Wu ^[1] ; Guanghui,Wang ^[1] ; Wei,Chen ^[1] ; Zhehui,Zhu ^[1] ; Yun,Liu ^[2] ; Zhenyu,Huang ^[1] ; Yuji,Huang ^[1] ; Peng,Du ^[1] ; Yili,Yang ^[3] ; Chen-Ying,Liu ^[4] ; Long,Cui ^[5]

作者单位： Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Shanghai Colorectal Cancer Research Center, Shanghai, China. ^[1] Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Suzhou Institute of Systems Medicine, Center for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China. ^[3] Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. liuchenying@xinhuamed.com.cn.;Shanghai Colorectal Cancer Research Center, Shanghai, China. liuchenying@xinhuamed.com.cn. ^[4] Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. cuilong@xinhuamed.com.cn.;Shanghai Colorectal Cancer Research Center, Shanghai, China. cuilong@xinhuamed.com.cn. ^[5]